 AnaptysBio Inc NASDAQ:ANAB has received an average rating of Hold from the twelve research firms that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, six have given a hold rating, four have given a buy rating and one has given a strong buy rating to ... 